Sunjin Pharmaceutical Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Sunjin Pharmaceutical General Information
Description
Developer of cell-based and peptide-based therapeutic products intended for the treatment of severe and intractable diseases, including central nervous system disorders and brain tumors. The company focuses on stem cell engineering, immune cell regulation, biomimetic peptide design, nanotechnology platforms, and engineered immune cell therapy development, enabling medical and biotechnology sectors to create targeted therapies with controlled cell activation, growth, and stabilization.
Contact Information
Website
www.sungenespharma.comCorporate Office
- BT-IT 405, Seoul Biohub
- 12 Opaesan-ro 3-gil, Seongbuk
- Seoul
- South Korea
Corporate Office
- BT-IT 405, Seoul Biohub
- 12 Opaesan-ro 3-gil, Seongbuk
- Seoul
- South Korea
Sunjin Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 05-Nov-2025 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Sunjin Pharmaceutical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kookmin University Technology Holdings | Venture Capital | Minority | ||
| Seoul Biohub | Accelerator/Incubator |
Sunjin Pharmaceutical FAQs
-
When was Sunjin Pharmaceutical founded?
Sunjin Pharmaceutical was founded in 2022.
-
Where is Sunjin Pharmaceutical headquartered?
Sunjin Pharmaceutical is headquartered in Seoul, South Korea.
-
What industry is Sunjin Pharmaceutical in?
Sunjin Pharmaceutical’s primary industry is Biotechnology.
-
Is Sunjin Pharmaceutical a private or public company?
Sunjin Pharmaceutical is a Private company.
-
What is Sunjin Pharmaceutical’s current revenue?
The current revenue for Sunjin Pharmaceutical is .
-
Who are Sunjin Pharmaceutical’s investors?
Kookmin University Technology Holdings and Seoul Biohub have invested in Sunjin Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process